SEC CIK 1732931
Alston Cheryl
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| GLview stock → | 16,621.037 | 2026-06-25 |
Position History — GL
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — GL
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-06-25 | Option exercise (derivative) | 14,017 | $0.00 | 0 |
| 2026-06-25 | Open-market sale | 2,564 | $180.57 | 16,621.037 |
| 2026-06-25 | Open-market sale | 1,934 | $180.13 | 19,185.037 |
| 2026-06-25 | Open-market sale | 1,010 | $178.71 | 21,119.037 |
| 2026-06-25 | Open-market sale | 2,750 | $177.56 | 22,129.037 |
| 2026-06-25 | Option exercise | 14,017 | $105.56 | 24,879.037 |
| 2026-01-02 | Grant / award | 1,373 | $0.00 | 10,835.95 |
| 2025-01-02 | Grant / award | 1,604 | $0.00 | 9,410.52 |
| 2024-01-02 | Grant / award | 1,475 | $0.00 | 7,738.11 |
| 2023-06-14 | Option exercise (derivative) | 7,217 | $0.00 | 0 |
| 2023-06-14 | Option exercise | 7,217 | $83.17 | 13,455.49 |
| 2023-06-14 | Option exercise | 9,474 | $76.37 | 22,929.49 |
| 2023-06-14 | Open-market sale | 16,691 | $108.81 | 6,238.49 |
| 2023-01-03 | Grant / award | 1,422 | $0.00 | 6,215.07 |
| 2023-01-03 | Grant / award | 1,422 | $0.00 | 6,154 |
| 2022-07-03 | Tax withholding | 395 | $100.34 | 4,732 |
| 2022-01-03 | Grant / award | 1,791 | $0.00 | 5,127 |
| 2021-07-04 | Tax withholding | 620 | $95.79 | 3,336 |
| 2021-01-04 | Grant / award | 2,814 | $0.00 | 3,956 |
| 2020-01-02 | Grant / award (derivative) | 14,017 | $0.00 | 14,017 |
| 2019-01-02 | Grant / award (derivative) | 9,474 | $0.00 | 9,474 |
| 2018-03-27 | Grant / award (derivative) | 6,835 | $0.00 | 6,835 |
| 2018-03-27 | Grant / award (derivative) | 7,217 | $0.00 | 7,217 |
| 2018-02-26 | — | — | — | 0 |
| 2018-02-26 | — | — | — | 0 |
| 2018-02-26 | Grant / award | 1,142 | $0.00 | 1,142 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.